IMPROVED METHOD FOR COMPARATIVE EVALUATION OF ALDOSTERONE ANTAGONISTS IN HEALTHY MAN

被引:12
作者
CASALSSTENZEL, J
SCHMALBACH, J
LOSERT, W
机构
[1] SCHERING AG, DEPT GEN PHARMACOL, FORSCHUNGSLAB, D-1000 BERLIN 65, FED REP GER
[2] KRANKENHAUS PORZ, KOLN, FED REP GER
关键词
D O I
10.1007/BF00607423
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:247 / 255
页数:9
相关论文
共 32 条
[1]  
ABSHAGEN U, 1976, N-S ARCH PHARMACOL, V293, pR62
[2]   RESPONSE OF NORMAL SUBJECTS TO LARGE AMOUNTS OF ALDOSTERONE [J].
AUGUST, JT ;
NELSON, DH ;
THORN, GW .
JOURNAL OF CLINICAL INVESTIGATION, 1958, 37 (11) :1549-1555
[3]   EFFECT OF SALURETICS AND SPIRONOLACTONE ON ALDOSTERONE PRODUCTION AND ELECTROLYTE EXCRETION IN MAN [J].
ERBLER, HC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) :145-156
[4]   MOLECULAR MODIFICATIONS OF ANTI-ALDOSTERONE COMPOUNDS - EFFECTS ON AFFINITY OF SPIRONOLACTONES FOR RENAL ALDOSTERONE RECEPTORS [J].
FUNDER, JW ;
FELDMAN, D ;
HIGHLAND, E ;
EDELMAN, IS .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (10) :1493-1501
[5]  
GOCHMAN N, 1962, J PHARMACOL EXP THER, V135, P312
[6]  
HERKEN H, 1958, N-S ARCH EX PATH PH, V234, P185
[7]  
HERKEN H, 1956, N-S ARCH EX PATH PH, V229, P123
[8]  
HERKEN H, 1963, Naunyn Schmiedebergs Arch Exp Pathol Pharmakol, V245, P289
[9]  
HERKEN H, 1969, HDB EXPTL PHARMACOLO, V24, P436
[10]  
HOFFMEISTER HE, 1968, POSTOPERATIVE STORUN, P241